Development and Validation of a Novel Prediction Model for Hearing Loss From Cisplatin Chemotherapy.

Saved in:
Bibliographic Details
Title: Development and Validation of a Novel Prediction Model for Hearing Loss From Cisplatin Chemotherapy.
Authors: Millstein J; University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA., Rassekh SR; Division of Pediatric Hematology/Oncology/BMT, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada., Brown AL; Department of Pediatrics, Baylor College of Medicine/Texas Children's Hospital, Cancer and Hematology Center, Houston, TX., Nie Q; University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA., Esbenshade AJ; Division of Pediatric Hematology and Oncology, Vanderbilt University Medical Center and the Vanderbilt Ingram Cancer Center, Nashville, TN., Knight KR; Department of Pediatric Audiology, Child Development and Rehabilitation Center, Doernbecher Children's Hospital, Oregon Health & Science University, Portland, OR., Scheurer ME; Department of Pediatrics, Baylor College of Medicine/Texas Children's Hospital, Cancer and Hematology Center, Houston, TX., Sung L; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada., Brooks B; British Columbia's Children's Hospital, Vancouver, BC, Canada.; School of Audiology and Speech Sciences, University of British Columbia, Vancouver, BC, Canada., Moke DJ; Department of Pediatrics, Southern California Kaiser Permanente-Lynwood, Lynwood, CA., Ross CJD; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada., Wright M; University of Tennessee Health Science Center, Memphis, TN., Mena V; Division of Rehabilitation Services, Hearing and Speech, Children's Hospital Los Angeles, Los Angeles, CA., Rushing T; Division of Hematology, Oncology and Blood & Marrow Transplantation, Department of Pharmacy, Children's Hospital Los Angeles, Cancer and Blood Diseases Institute, Los Angeles, CA., Carleton BC; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Orgel E; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA.; Keck School of Medicine, University of Southern California, Los Angeles, CA.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Jul; Vol. 43 (19), pp. 2173-2183. Date of Electronic Publication: 2025 May 05.
Publication Type: Journal Article; Validation Study; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO-24-01861